T. Rowe Price Associates’s Agenus AGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $82K | Hold |
24,500
| – | – | ﹤0.01% | 3031 |
|
|
2025
Q4 | $77K | Buy |
+24,500
| New | +$97.6K | ﹤0.01% | 2978 |
|
|
2025
Q2 | – | Sell |
-10,056
| Closed | -$16K | – | 3060 |
|
|
2025
Q1 | $16K | Buy |
+10,056
| New | +$29K | ﹤0.01% | 3013 |
|
|
2024
Q4 | – | Sell |
-21,072
| Closed | -$116K | – | 3013 |
|
|
2024
Q3 | $116K | Buy |
21,072
+231
| +1% | +$1.73K | ﹤0.01% | 2792 |
|
|
2024
Q2 | $350K | Buy |
20,841
+2,945
| +16% | +$35.6K | ﹤0.01% | 2348 |
|
|
2024
Q1 | $208K | Buy |
17,896
+6,153
| +52% | +$81.6K | ﹤0.01% | 2606 |
|
|
2023
Q4 | $195K | Buy |
11,743
+443
| +4% | +$7.34K | ﹤0.01% | 2553 |
|
|
2023
Q3 | $256K | Buy |
11,300
+1,446
| +15% | +$41K | ﹤0.01% | 2406 |
|
|
2023
Q2 | $316K | Buy |
9,854
+516
| +6% | +$16.5K | ﹤0.01% | 2339 |
|
|
2023
Q1 | $279K | Sell |
9,338
-388
| -4% | -$16.4K | ﹤0.01% | 2381 |
|
|
2022
Q4 | $458K | Buy |
9,726
+377
| +4% | +$19.2K | ﹤0.01% | 2168 |
|
|
2022
Q3 | $377K | Buy |
9,349
+1,040
| +13% | +$53K | ﹤0.01% | 2270 |
|
|
2022
Q2 | $316K | Buy |
8,309
+1,480
| +22% | +$53.7K | ﹤0.01% | 2420 |
|
|
2022
Q1 | $330K | Buy |
6,829
+648
| +10% | +$35K | ﹤0.01% | 2518 |
|
|
2021
Q4 | $391K | Buy |
6,181
+3,909
| +172% | +$308K | ﹤0.01% | 2499 |
|
|
2021
Q3 | $234K | Sell |
2,272
-5
| -0.2% | -$565 | ﹤0.01% | 2666 |
|
|
2021
Q2 | $245K | Buy |
2,277
+327
| +17% | +$24.5K | ﹤0.01% | 2652 |
|
|
2021
Q1 | $104K | Buy |
1,950
+32
| +2% | +$2.31K | ﹤0.01% | 2777 |
|
|
2020
Q4 | $120K | Sell |
1,918
-59,136
| -97% | -$4.39M | ﹤0.01% | 2614 |
|
|
2020
Q3 | $4.79M | Sell |
61,054
-34,147
| -36% | -$2.66M | ﹤0.01% | 1408 |
|
|
2020
Q2 | $7.34M | Buy |
95,201
+91,675
| +2,600% | +$5.49M | ﹤0.01% | 1344 |
|
|
2020
Q1 | $170K | Buy |
3,526
+34
| +1% | +$2.13K | ﹤0.01% | 2345 |
|
|
2019
Q4 | $279K | Buy |
3,492
+219
| +7% | +$14.7K | ﹤0.01% | 2338 |
|
|
2019
Q3 | $166K | Buy |
3,273
+1,604
| +96% | +$85.8K | ﹤0.01% | 2404 |
|
|
2019
Q2 | $98K | Sell |
1,669
-2,548
| -60% | -$139K | ﹤0.01% | 2481 |
|
|
2019
Q1 | $246K | Buy |
4,217
+16
| +0.4% | +$993 | ﹤0.01% | 2354 |
|
|
2018
Q4 | $196K | Sell |
4,201
-1,644
| -28% | -$68.6K | ﹤0.01% | 2413 |
|
|
2018
Q3 | $246K | Buy |
5,845
+2,307
| +65% | +$90.8K | ﹤0.01% | 2412 |
|
|
2018
Q2 | $158K | Buy |
3,538
+5
| +0.1% | +$337 | ﹤0.01% | 2488 |
|
|
2018
Q1 | $327K | Buy |
3,533
+7
| +0.2% | +$622 | ﹤0.01% | 2260 |
|
|
2017
Q4 | $226K | Buy |
3,526
+1,972
| +127% | +$151K | ﹤0.01% | 2384 |
|
|
2017
Q3 | $135K | Hold |
1,554
| – | – | ﹤0.01% | 2469 |
|
|
2017
Q2 | $119K | Buy |
1,554
+662
| +74% | +$46.6K | ﹤0.01% | 2460 |
|
|
2017
Q1 | $66K | Hold |
892
| – | – | ﹤0.01% | 2524 |
|
|
2016
Q4 | $72K | Buy |
+892
| New | +$87.6K | ﹤0.01% | 2497 |
|
Other funds holding AGEN
VCM
VPM
SL
T. Rowe Price Associates's AGEN Position: Q1 2026 in Review
T. Rowe Price Associates held its Agenus (AGEN) position steady in Q1 2026 at 24,500 shares worth $82K. The position accounts for ﹤0.01% of the portfolio, ranked #3031.
T. Rowe Price Associates first reported a position in AGEN in Q4 2016 and has held it in 35 quarters since. The position peaked at $7.34M in Q2 2020. 88 funds tracked by Wall St. Rank hold AGEN as of Q1 2026.
- T. Rowe Price Associates held 24,500 shares of Agenus worth $82K as of Q1 2026.
- T. Rowe Price Associates left its Agenus share count unchanged in Q1 2026.
- Agenus made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #3031 holding.
- T. Rowe Price Associates first reported a position in Agenus in Q4 2016 and has held it in 35 quarters since.
- T. Rowe Price Associates's Agenus position peaked at $7.34M in Q2 2020.
- 88 funds tracked by Wall St. Rank held Agenus as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.